Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Is there a need for "triple therapy"? Role of anticoagulation with dual antiplatelet therapy in acute coronary syndromes (ATLAS Study & TRAP Study).

Patrick WL, Patel C, Guddeti R, Narayan A, Maddaleni M, Kumar S, Dolma K, Serla VV, Sangha M, Govindavarjhulla A, Saddala P, Singh P, Halaby R, Gibson CM.

Curr Cardiol Rep. 2013 Oct;15(10):411. doi: 10.1007/s11886-013-0411-1. Review.

PMID:
24022544
2.

Safety of new oral anticoagulants with dual antiplatelet therapy in patients with acute coronary syndromes.

Tsu LV, Dager WE.

Ann Pharmacother. 2013 Apr;47(4):573-7. doi: 10.1345/aph.1R576. Review.

PMID:
23548645
3.

New oral anticoagulants in addition to single or dual antiplatelet therapy after an acute coronary syndrome: a systematic review and meta-analysis.

Oldgren J, Wallentin L, Alexander JH, James S, Jönelid B, Steg G, Sundström J.

Eur Heart J. 2013 Jun;34(22):1670-80. doi: 10.1093/eurheartj/eht049. Review.

4.

High platelet reactivity--the challenge of prolonged anticoagulation therapy after ACS.

Brouwer MA, Jaspers Focks J, Verheugt FW.

Thromb Haemost. 2013 May;109(5):799-807. doi: 10.1160/TH12-08-0582. Review.

PMID:
23426079
5.

Role of novel and emerging oral anticoagulants for secondary prevention of acute coronary syndromes.

Ganetsky VS, Hadley DE, Thomas TF.

Pharmacotherapy. 2014 Jun;34(6):590-604. doi: 10.1002/phar.1375. Review.

PMID:
24338703
6.

Improving long-term ACS management: is there a role for the new antiplatelets?

Cohen M.

J Interv Cardiol. 2012 Oct;25(5):425-32. doi: 10.1111/j.1540-8183.2012.00738.x. Review.

PMID:
22574644
8.

Insights into the role of thrombin in the pathogenesis of recurrent ischaemia after acute coronary syndrome.

Weitz JI.

Thromb Haemost. 2014 Nov;112(5):924-31. doi: 10.1160/TH14-03-0265. Review.

PMID:
25030773
9.

Reduction of stent thrombosis in patients with acute coronary syndromes treated with rivaroxaban in ATLAS-ACS 2 TIMI 51.

Gibson CM, Chakrabarti AK, Mega J, Bode C, Bassand JP, Verheugt FW, Bhatt DL, Goto S, Cohen M, Mohanavelu S, Burton P, Stone G, Braunwald E; ATLAS-ACS 2 TIMI 51 Investigators..

J Am Coll Cardiol. 2013 Jul 23;62(4):286-90. doi: 10.1016/j.jacc.2013.03.041.

10.

The potential role of anticoagulant therapy for the secondary prevention of ischemic events post-acute coronary syndrome.

Camuglia AC, Waddell-Smith KE, Hammett CJ, Aylward PE.

Curr Med Res Opin. 2014 Nov;30(11):2151-67. doi: 10.1185/03007995.2014.949647. Review.

PMID:
25140867
11.

Increased prevalence of cardiovascular risk factors in patients with acute coronary syndrome and indications for treatment with oral anticoagulation.

Owsiak M, Pelc-Nowicka A, Badacz L, Dubiel J, Dudek D, Gajos G, Grodecki J, Jankowski P, Kawecka-Jaszcz K, Mirek-Bryniarska E, Nessler J, Podolec P, Sadowski J, Tracz W, Zabojszcz M, Żmudka K, Bryniarski L.

Kardiol Pol. 2011;69(9):907-12.

12.
13.

Rivaroxaban (Xarelto) for acute coronary syndrome.

[No authors listed]

Med Lett Drugs Ther. 2011 Dec 12;53(1379-1380):97.

PMID:
22173426
14.

[Anticoagulants and dual antiplatelet therapy combined, a challenge to our intelligence].

Morais J.

Rev Port Cardiol. 2012 Apr;31 Suppl 1:38-44. Portuguese.

PMID:
22541034
15.

Developments in antiplatelet therapy for acute coronary syndromes and considerations for long-term management.

Cowley MJ, Kuritzky L.

Curr Med Res Opin. 2009 Jun;25(6):1477-90. doi: 10.1185/03007990902864590. Review.

PMID:
19419337
16.

Antiplatelet and anticoagulant therapies in acute coronary syndromes.

Hanna EB, Glancy DL, Saucedo JF.

Cardiovasc Drugs Ther. 2010 Feb;24(1):61-70. doi: 10.1007/s10557-009-6212-5. Review.

PMID:
20033270
17.

The "dual-pathway" strategy after acute coronary syndrome: rivaroxaban and antiplatelet agents in the ATLAS ACS 2-TIMI 51 trial.

Cohen M, Iyer D.

Cardiovasc Ther. 2014 Oct;32(5):224-32. doi: 10.1111/1755-5922.12083. Review.

19.

Novel antiplatelet strategies in acute coronary syndromes.

Sabatine MS.

Cleve Clin J Med. 2009 Apr;76 Suppl 1:S8-15. doi: 10.3949/ccjm.76.s1.02.

20.

Antiplatelet and anticoagulation therapy for acute coronary syndromes.

Bhatt DL, Hulot JS, Moliterno DJ, Harrington RA.

Circ Res. 2014 Jun 6;114(12):1929-43. doi: 10.1161/CIRCRESAHA.114.302737. Review.

Items per page

Supplemental Content

Support Center